American Society for Microbiology, Infection and Immunity, 3(54), p. 909-912, 1986
DOI: 10.1128/iai.54.3.909-912.1986
Full text: Download
Treatment of Leishmania major-infected, genetically susceptible BALB/c mice with the T-lymphocyte-immunosuppressive drug cyclosporin A (CyA) resulted in a significantly reduced parasite burden in the local site of infection and in the draining lymph nodes. These data indicate that T cells are pivotal for the propagation of L. major in vivo.